Here"s Why Sangamo Therapeutics Lost 12% Today
What hap.....»»
Why Brown-Forman, Acorda Therapeutics, and Energy XXI Gulf Coast Slumped Today
Find out which of these companies lost the most ground......»»
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
SOUTH SAN FRANCISCO, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) (NASDAQ:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported.....»»
Why F-star Therapeutics" Stock Is Trading Lower Today
F-star Therapeutics (NASDAQ:FSTX) shares are trading lower after the company priced its 9.29 million shares common stock offering at $7 per share. read more.....»»
Why Athenex"s Stock Is Trading Higher Today
Athenex's (NASDAQ:ATNX) shares are trading higher after the company announced it acquired Kuur Therapeutics. read more.....»»
Why Sorrento Therapeutics" Stock Is Trading Higher Today
Sorrento Therapeutics (NASDAQ: SRNE) shares are trading higher after the company received FDA clearance to proceed with its Phase 2 study for Sti-3031 in advanced urothelial carcinoma. read more.....»»
Why Is It Moving? Looking At LAVA Therapeutics"s Price Action Today
LAVA Thera.....»»
What"s Going On With GALT Stock And TV Stock Today?
Galectin Therapeutics Inc (NASDAQ: GALT) sh.....»»
Ex-Rep. Katie Hill loses lawsuit against Daily Mail for publishing nude photos of her, accuses judge of thinking "revenge porn is free speech"
"Today, we lost in court because a judge - not a jury - thinks revenge porn is free speech," Hill twee.....»»
Taxes Q&A: How do I get my stimulus lost in the mail? Do I owe taxes on PUA payments?
How do I file if I didn't got a Notice 1444? I never got my mailed stimulus, can I claim it? USA TODAY Money repor.....»»
Why Are Neos Therapeutics, Aytu BioScience Stocks Soaring Today?
Neos Therapeutics Inc (NASDAQ: NEOS) and Aytu BioScience Inc (NASDAQ: read more.....»»
Analyzing The Price Action In Oncternal Therapeutics Stock Today
The Price And Volume Action In Oncternal Therapeutics's S.....»»
Why Pandion Therapeutics Stock Shot Up 133% Today
Pandion Therapeutics Inc (NASDAQ: PAND) shares closed over 133% higher today. read more.....»»
Why Monopar Therapeutics And EyePoint Pharma Are Trading Higher Today
Monopar Therapeutics (NASDAQ: MNPR) shares are trading higher Thursday after Roth Capital initiated coverage on the stock with a Buy rating and a price target of $49 per share. read more.....»»
Why Anthem, Frequency Therapeutics And Vir Are Moving Today
Vir Biotechnology (NASDAQ: VIR) shares are trading lower Wednesday after JPMorgan downgraded the stock from Neutral to Underweight and announced a price target of $30 per share. read more.....»»
Why Fluidigm, Seelos Therapeutics And More Are Moving Today
Fluidigm (NASDAQ: FLDM) shares are trading higher Friday after the company announced it received the CE-IVD mark for its Advanta Dx SARS-CoV-2 RT-PCR Assay. read more.....»»
: Sarepta stock plunges more than 50% after mixed results from drug study
Sarepta Therapeutics Inc. shares lost more than half their value in after-hours trading Thursday, after the company said a drug candidate produced mixed results in a clinical study......»»
Sangamo Therapeutics initiated at hold with $16 price target at Stifel
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Why Is It Moving? Analyzing The Downward Movement in Addex Therapeutics"s Stock Today
The Price And Volume Action In Addex Therapeu.....»»
Why Turning Point"s Stock Is Trading Higher Today
Turning Point Therapeutics (NASDAQ: TPTX) shares are trading higher on Wednesday. Wells Fargo has maintained its Overweight rating on the stock and raised its price target from $62 to $76 per share. .....»»
Eidos Therapeutics Reports First Quarter 2020 Financial Results and Business Update
SAN FRANCISCO, May 08, 2020 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (NASDAQ:EIDX), Â today reported its financial results for the first qu.....»»